...
首页> 外文期刊>Health technology assessment: HTA >Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial.
【24h】

Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial.

机译:扑热息痛和布洛芬用于治疗儿童发烧:PITCH随机对照试验。

获取原文
           

摘要

OBJECTIVES: To establish the relative clinical effectiveness and cost-effectiveness of paracetamol plus ibuprofen compared with paracetamol and ibuprofen separately for time without fever, and the relief of fever-associated discomfort in young children who can be managed at home. DESIGN: The trial design was a single-centre (multisite), individually randomised, blinded, three-arm trial comparing paracetamol and ibuprofen together with paracetamol or ibuprofen separately. SETTING: There were three recruitment settings, as follows: 'local' where research nurses were recruited from NHS primary care sites; 'remote' where NHS sites notified the study of potentially eligible children; and 'community' where parents contacted the study in response to local media advertisements. PARTICIPANTS: Children aged between 6 months and 6 years with fever > or = 37.8 degrees C and < or = 41 degrees C due to an illness that could be managed at home. INTERVENTIONS: The intervention was the provision of, and advice to give, the medicines for up to 48 hours: paracetamol every 4-6 hours (maximum of four doses in 24 hours) and ibuprofen every 6-8 hours (maximum of three doses in 24 hours). Every parent received two bottles, with at least one containing an active medicine. Parents, research nurses and investigators were blinded to treatment allocation by the use of identically matched placebo medicines. The dose of medicine was determined by the child's weight: paracetamol 15 mg/kg and ibuprofen 10 mg/kg per dose. RESULTS: For additional time without fever in the first 4 hours, use of both medicines was superior to use of paracetamol alone [adjusted difference 55 minutes, 95% confidence interval (CI) 33 to 77 minutes; p < 0.001] and may have been as good as ibuprofen (adjusted difference 16 minutes, 95% CI -6 to 39 minutes; p = 0.2). Both medicines together cleared the fever 23 minutes (95% CI 2-45 minutes; p = 0.015) faster than paracetamol alone, but no faster than ibuprofen alone (adjusted difference -3 minutes, 95% CI 24-18 minutes; p = 0.8). For additional time without fever in the first 24 hours, both medicines were superior to paracetamol (adjusted difference 4.4 hours, 95% CI 2.4-6.3 hours; p < 0.001) or ibuprofen (adjusted difference 2.5 hours, 95% CI 0.6-4.5 hours; p = 0.008) alone. No reduction in discomfort or other fever-associated symptoms was found, although power was low for these outcomes. An exploratory analysis showed that children with higher discomfort levels had higher mean temperatures. No difference in adverse effects was observed between treatment groups. The recommended maximum number of doses of paracetamol and ibuprofen in 24 hours was exceeded in 8% and 11% of children respectively. Over the 5-day study period, paracetamol and ibuprofen together was the cheapest option for the NHS due to the lower use of health-care services:14 pounds [standard deviation (SD) 23 pounds] versus 20 pounds (SD 38 pounds) for paracetamol and 18 pounds (SD 40 pounds) for ibuprofen. Both medicines were also cheapest for parents because the lower use of health care services resulted in personal saving on travel costs and less time off work: 24 pounds (SD 46 pounds) versus 26 pounds (SD 63 pounds) for paracetamol and 30 pounds (SD 91 pounds) for ibuprofen. This more than compensated for the extra cost of medication. However, statistical evidence for these differences was weak due to lack of power. Overall, a quarter of children were 'back to normal' by 48 hours and one-third by day 5. Five (3%) children were admitted to hospital, two with pneumonia, two with bronchiolitis and one with a severe, but unidentified 'viral illness'. CONCLUSIONS: Young children who are unwell with fever should be treated with ibuprofen first, but the relative risks (inadvertently exceeding the maximum recommended dose) and benefits (extra 2.5 hours without fever) of using paracetamol plus ibuprofen over 24 hours should be considered. However, if two medicines are used, i
机译:目的:建立对乙酰氨基酚加布洛芬与对乙酰氨基酚和布洛芬分别比较不发烧的相对临床疗效和成本效益,并减轻可在家治疗的年幼儿童与发烧相关的不适。设计:试验设计为单中心(多部位),单独随机化,盲法,三臂试验,比较了扑热息痛和布洛芬以及扑热息痛或布洛芬。场所:共有三种招聘设置,如下:“本地”,即从NHS初级保健地点招聘研究护士的地方; NHS站点通知潜在合格儿童的研究的“远程”;以及“社区”,即父母根据当地媒体的广告与研究进行联系的地方。参与者:6个月至6岁之间的儿童,由于在家中可治病,发烧>或= 37.8摄氏度且<或= 41摄氏度。干预措施:干预是提供和建议给予长达48小时的药物:每4-6小时一次扑热息痛(24小时内最多服用四剂)和布洛芬每6-8小时(一次内最多服用三剂) 24小时)。每个父母都会收到两瓶,其中至少一瓶装有活性药物。父母,研究护士和研究人员对使用相同匹配安慰剂药物的治疗方法视而不见。药物的剂量取决于孩子的体重:每剂对乙酰氨基酚15 mg / kg和布洛芬10 mg / kg。结果:在开始的4小时内没有发烧的额外时间,两种药物的使用均优于单独使用扑热息痛[调整后的差55分钟,95%的置信区间(CI)为33至77分钟; p <0.001],可能与布洛芬一样好(调整后的差异为16分钟,95%CI -6至39分钟; p = 0.2)。两种药物共同清除发烧的时间比单独使用扑热息痛快23分钟(95%CI 2-45分钟; p = 0.015),但不比单独使用布洛芬快(校正差-3分钟,95%CI 24-18分钟; p = 0.8)。 )。对于在开始的24小时内没有发烧的额外时间,两种药物均优于扑热息痛(调整后差异4.4小时,95%CI 2.4-6.3小时; p <0.001)或布洛芬(调整后差异2.5小时,95%CI 0.6-4.5小时) ; p = 0.008)。尽管这些结果的功效很低,但并未发现不适或其他发烧相关症状的减轻。一项探索性分析表明,不适水平较高的儿童的平均温度较高。治疗组之间未观察到不良反应的差异。儿童中对乙酰氨基酚和布洛芬在24小时内的建议最大剂量分别超过了8%和11%的儿童。在为期5天的研究期内,由于对卫生保健服务的使用较少,扑热息痛和布洛芬合在一起是NHS的最便宜选择:14磅[标准差(SD)23磅]比20磅(SD 38磅)扑热息痛和布洛芬:18磅(SD为40磅)。这两种药物对父母来说也是最便宜的,因为对医疗保健服务的较少使用可以节省个人的​​差旅费和下班时间:对乙酰氨基酚为24磅(SD 46磅),而扑热息痛和30磅(SD)为26磅(SD 63磅)。布洛芬(91磅)。这远远弥补了额外的药物治疗费用。但是,由于缺乏权力,这些差异的统计证据很薄弱。总体而言,四分之一的孩子在48小时之前“恢复正常”,三分之一在第5天时“恢复正常”。五(3%)名儿童入院,两名患有肺炎,两名患有毛细支气管炎,一名患有严重但不明的“病毒性疾病”。结论:发烧不佳的幼儿应首先用布洛芬治疗,但应考虑在24小时内使用扑热息痛加布洛芬的相对风险(无意超过最大推荐剂量)和获益(不发烧额外2.5小时)。但是,如果使用两种药物,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号